Research | Detailed technology
Updated July. 2026

3D Bioprinting system
(2018 - current)
Manufacturing multi-heads 3D bioprinters
Upgrade 3D bioprinting software and system
Supervising, Mentoring, Motor control, System optimization, Regulatory, CAD/CAM, Industry translation
Ulsan National Institute of Science and Technology · Nova Therapeutics Inc · Wake Forest Institute for Regenerative Medicine

Digital Light Processing Printing
(2025 - current)
Manufacturing Functional Kidney Unit for Cortex Reconstruction
Supervising, Mentoring, Automated image analysis,
Materials synthesis,, Photoxicy, Primary cell, Bioink
ARPA-H
Wake Forest Institute for Regenerative Medicine
(Example cannot be shared as compliance)

NAMs:
In vitro advanced tissue model
(2018 - current)
Patient and iPSC-derived organoids
System fabrication, Manufacturing, Optimization and Validation for physiology, Histology, Drug screening
Ulsan National Institute of Science and Technology
Wake Forest Institute for Regenerative Medicine

Space Biomanufacturing
Lead Scientist (2025- current)
Bioprinting iPSC-derived hepatic organoids/tissue for microgravity and low-earth orbit biotechnology research.
Optimization, Ground control, Biochemical Analysis
Axiom Space · Hallym University · Hanyang University · Wake Forest Institute for Regenerative Medicine

Universal Bioink Platform
Lead Scientist (2025 - current)
Development of tissue-specific and cytocompatible bioinks for 3D bioprinting application
Supervising, SOP, QC, Scale-up manufacturing, Mechanical charaterization, Industry translation, Publication, IPs
NSF Regenerative Medicine Engine · North Carolina Agricultural and Technical State University (NCAT), Wake Forest Institute for Regenerative Medicine


NAMs:
In vitro composite muscle tissue
Lead Scientist (2025 - current)
Integration of iPSC-derived sensory neuron organoids/tissue
Myosteatosis platform for senescence and metabolic dysfunction
High-throughput screening for toxicology and pharmacology
SOPs, Mentoring, 3D manufacturing, Publication, IPs
National Center for Advancing Translational Science, NIH · Seoul Catholic University · Wake Forest Institute for Regenerative Medicine


Tumor microenvironment
Lead Scientist (2022 - current)
High-throughput drug screening of patient-derived breast cancer organoids
Therapeutic intervention of adipose tissue and mechanistics for cancer TMEs
New Approach Methodologies (NAMs), Bioanalytics, 3D Bioprinting, Publication, IPs
Wake Forest Organoid Research Center · Ulsan National Institute of Science and Technology · Wake Forest Institute for Regenerative Medicine

Type 1 Diabetes
Lead Scientist (2022 - 2024)
3D Bioprinting of human primary pancreatic islets structure for Type 1 Diabetes
New Approach Methodologies (NAMs), 3D Bioprinting, Decellularization, SOPs, In vivo, Bionalytics, Publication, IPs
Juvenile Diabetes Research Foundation · University of Miami Miller School of Medicine · Imagine Pharma · Wake Forest Institute for Regenerative Medicine

Organ Mimetic Research
Scientist (2018 - 2020)
Development of artificial organ manufacturing technology
Soft tissue engineering for volumetric reconstruction
New Approach Methodologies (NAMs), Bioanalytics, 3D Bioprinting, Decellularization, SOPs, In vivo, Bionalytics, Publication, IPs
University of Basel · Ulsan National Institute of Science and Technology · Ulsan Asan Hospital · Wake Forest Institute for Regenerative Medicine